Financial Performance - The basic earnings per share decreased by 12.5% from 0.1600 yuan in 2023 to 0.1400 yuan in 2024 [1] - The total revenue increased by 18.27%, rising from 9.25 billion yuan in 2023 to 10.94 billion yuan in 2024 [1] - The net profit decreased by 10.26%, from 0.39 billion yuan in 2023 to 0.35 billion yuan in 2024 [1] - The return on equity fell by 14.92%, from 6.77% in 2023 to 5.76% in 2024 [1] - The net asset per share increased by 4.08%, from 2.45 yuan in 2023 to 2.55 yuan in 2024 [1] - The undistributed profits per share increased by 7.89%, from 1.14 yuan in 2023 to 1.23 yuan in 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 80.9689 million shares, accounting for 33.74% of the circulating shares, with an increase of 4.5409 million shares compared to the previous period [1] - Shanghai Kaikai (Group) Co., Ltd. remains the largest shareholder with 64.4098 million shares, representing 26.84% of the total share capital [2] - New entrants among the top shareholders include Zhao Liqian, Sun Chengyuan, and Zhao Guohua, holding 2.3962 million shares, 2.2533 million shares, and 1.6120 million shares respectively [2] - Goldman Sachs LLC and other shareholders have exited the top ten list [2] Dividend Distribution - The company announced a dividend distribution of 0.44 yuan per share (including tax) [3]

| 股票代码：600272 | 股票简称：开开实业 编号：2024—053 | | --- | --- | | 900943 | 开开 B 股 | 上海开开实业股份有限公司 关于参加 2024 年上海辖区上市公司集体接待日 暨中报业绩说明会召开情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 上海开开实业股份有限公司（以下简称："公司"）（以下简称 "公司"）于 2024 年 9 月 13 日（星期五）下午 14:00-16:30 参加由 上海上市公司协会与深圳市全景网络有限公司联合举办的"2024 年 上海辖区上市公司集体接待日暨中报业绩说明会"，以网络文字互动 方式就投资者关心的问题进行了交流。关于本次业绩说明会的召开事 项，详见公司 2024 年 9 月 7 日在《上海证券报》《香港商报》和上 海证券交易所网站（www.sse.com.cn）2024-052 号公告。现将召开情 况公告如下： 一、业绩说明会召开情况 召开时间：2024 年 9 月 13 日（周五）14:00-16:30，其中网络文 字互动交 ...

| 股票代码：600272 | 股票简称：开开实业 编号：2024—052 | | --- | --- | | 900943 | 开开 B 股 | 上海开开实业股份有限公司 关于参加 2024 年上海辖区上市公司集体接待日 暨中报业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ●会议召开时间：2024 年 9 月 13 日（周五）14:00-16:30，其中网 络文字互动交流时间为 15:00-16:30 ●会议召开地点： "全景路演"网站 （https://rs.p5w.net/html/143790.shtml） ●会议召开方式：网络文字互动方式 ●投资者可于2024年9月9日（周一）至9月11日（周三）16:00前 通过公司邮箱dm@chinesekk.com进行提问。公司将在业绩说明会上 对投资者普遍关注的问题进行回答。 三、参加人员 董事、总经理： 刘光靓先生 上海开开实业股份有限公司（以下简称"公司"）已于《上海证 券报》《香港商报》及上海证券交易所网站（www.sse.com ...

2024 年半年度报告 公司代码：600272 公司简称：开开实业 900943 开开 B 股 上海开开实业股份有限公司 2024 年半年度报告 1 / 133 2024 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人庄虔贇、主管会计工作负责人刘光靓及会计机构负责人（会计主管人员）陈珩声 明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 公司无半年度利润分配预案或资本公积金转增股本预案。 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的未来计划、发展战略等前瞻性描述乃基于当前能够掌握的信息与数据对未 来所做出的估计或预测，不构成公司对投资者的实质承诺，敬请投资者注意投资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 是否存在半数以 ...

Financial Performance - The company achieved operating revenue of RMB 925.07 million in 2023, an increase of 3.46% compared to 2022[25]. - Net profit attributable to shareholders was RMB 39.30 million, a decrease of 1.57% from the previous year[26]. - The basic earnings per share remained at RMB 0.16, consistent with the previous year[25]. - The net cash flow from operating activities was RMB 578.43 thousand, a significant decrease of 99.27% compared to 2022[28]. - The weighted average return on equity decreased to 6.77%, down 0.49 percentage points from 2022[25]. - The company reported a total asset increase of 9.61% year-over-year, reaching RMB 1.33 billion by the end of 2023[25]. - Non-recurring gains and losses totaled RMB 29.85 million, compared to RMB 25.79 million in 2022[32]. - The company’s net assets attributable to shareholders increased by 4.77% to RMB 595.83 million[25]. - The gross profit margin decreased by 3.53 percentage points to 18.81% compared to the previous year[67]. - The company reported a significant decrease in cash flow from operating activities, with a net cash flow of RMB 578.43 thousand, down 99.27% year-on-year[64]. Dividend and Shareholder Information - The company plans to distribute a cash dividend of RMB 0.49 per 10 shares to all shareholders, totaling RMB 11,907,000.00 (including tax) for the year 2023[7]. - The company does not plan to issue bonus shares or convert capital reserves into share capital for the current year[7]. - The company has maintained a consistent cash dividend policy, distributing dividends for 11 consecutive years, with a payout ratio exceeding 30% of the net profit each year[140]. - The total pre-tax compensation for the board members and senior management during the reporting period amounted to 3.8258 million CNY[116]. - The company has established effective communication channels with shareholders, holding two general meetings during the reporting period[111]. Governance and Compliance - The company has received a standard unqualified audit report from its accounting firm, ensuring the accuracy and completeness of the financial report[6]. - The board of directors has confirmed that all members attended the board meeting, ensuring proper governance and decision-making[5]. - The company emphasizes balancing the interests of shareholders, employees, and society while fulfilling social responsibilities[113]. - The company has revised its internal control system to enhance risk management and ensure compliance with regulatory requirements[113]. - The company continues to focus on governance and compliance with a well-structured board of directors[117]. Business Strategy and Development - The company plans to focus on the "big health" transformation strategy, aiming for high-quality development and optimizing its industrial structure[96]. - The pharmaceutical segment will leverage digital capabilities to transform its core businesses, focusing on "medicine, healthcare, and elderly care," while addressing challenges from recent healthcare reforms[101]. - The company is transitioning from traditional pharmaceutical retail to a focus on health services, integrating digital health initiatives into its business model[53]. - The company is committed to innovation-driven transformation and enhancing core competitiveness to achieve high-quality growth[108]. - The company is exploring partnerships with international firms to expand its product offerings in overseas markets[121]. Risk Management and Challenges - The company has outlined various risks and corresponding countermeasures in the management discussion and analysis section of the report[9]. - The pharmaceutical sector faces challenges due to price reductions from policies like two-invoice system and centralized procurement, prompting the company to explore a tri-wheel development strategy of "pharmaceuticals, medical care, and health care"[97]. - The company faces macroeconomic risks due to policy impacts on the retail sector, necessitating a focus on confidence-building and reform[106]. - The transformation efforts may face risks related to market uncertainty and the time required for new business models to mature, potentially impacting short-term profitability[107]. Product and Market Development - The company has introduced multiple new products, including Lingzhi spore powder and health teas, while its cultural brand "Yunshang Life" received awards for innovative products[39]. - The company has established the "Cloud Pharmacy" platform, connecting with 15 community health service centers to enhance drug delivery services, aiming for efficient and safe pharmaceutical services[38]. - The company has launched a comprehensive reform of its apparel sector, aiming to streamline management and enhance decision-making efficiency through the consolidation of subsidiaries[47]. - The company has introduced over 100 new products in the pharmaceutical retail sector, leveraging its supply chain advantages amid regulatory changes[44]. - The company is focusing on integrating traditional Chinese medicine with health services, exploring new business models in the healthcare sector[44]. Community and Environmental Responsibility - The company has committed approximately 600,000 yuan annually to support rural revitalization efforts in designated areas[49]. - The company invested CNY 5.08 million in environmental protection during the reporting period[149]. - The company has actively participated in community service and public welfare activities, promoting regional economic development[154]. - Total investment in poverty alleviation and rural revitalization projects amounted to 500,000 RMB[155]. Management and Organizational Structure - The company is led by a diverse team with extensive experience in various sectors, including finance, management, and law[117]. - The company has undergone several management changes, including the resignation of Gao Dongming and the retirement of Vice President Cen Zhijian[123]. - The company has implemented a training program focused on enhancing employee skills and knowledge to support sustainable development[137]. - The company has established a comprehensive internal control system that meets management requirements and ensures the authenticity and fairness of financial reporting[132]. Market Performance and Customer Engagement - The retail industry is experiencing a recovery, with consumer confidence steadily increasing, leading to a resurgence in demand[50]. - User data showed a 20% increase in active users, reaching 5 million by the end of the reporting period[120]. - The company is expanding its market presence, targeting a 25% increase in retail locations over the next year[121]. - The company’s clothing segment achieved a main business income of RMB 79.52 million, an increase of 16.29% year-on-year, with a gross margin of 7.54%[64].

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | 股票代码：600272 900943 | | | | --- | --- | --- | | | 股票简称：开开实业 | 编号：2023—039 | | | 开开 B 股 | | 上海开开实业股份有限公司 关于 2023 年半年度报告业绩说明会召开情况的公告 上海开开实业股份有限公司（以下简称"公司"）于 2023 年 9 月 7 日（星期四）下午 14:00-16:30 参加了"2023 年上海辖区上市公司 集体接待日暨中报业绩说明会"活动，以网络文字互动方式召开了公 司 2023 年半年度报告业绩说明会。关于本次业绩说明会的召开事项， 详见 2023 年 9 月 2 日在《上海证券报》《香港商报》和上海证券交 易所网站（www.sse.com.cn）上的公司《关于参加 2023 年上海辖区上 市公司集体接待日暨 2023 年半年度报告业绩说明会的公告》（公告 编号：2023-037）。现将召开情况公告如下： 一、业绩说明会召开情况 2023 年 9 月 7 日，公司董事、 ...

| | | 上海开开实业股份有限公司 关于参加 2023 年上海辖区上市公司集体接待日 暨 2023 年半年度报告业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●会议召开时间：2023 年 9 月 7 日（星期四）下午 14:00-16:30， 其中网络文字互动交流时间为 15:00-16:30 ●会议召开地点："全景路演"网站（http://rs.p5w.net/） ●会议召开方式：网络文字互动方式 ●投资者可在业绩说明会召开前，扫描本公告中的二维码提前 留言提问。公司将在业绩说明会上对投资者普遍关注的问题进行回 答。 上海开开实业股份有限公司（以下简称"公司"）已于 2023 年 8 月 26 日在《上海证券报》《香港商报》及上海证券交易所网站 （www.sse.com.cn）披露了公司《2023 年半年度报告及报告摘要》。 为便于广大投资者更深入全面地了解公司 2023 年半年度经营成果、 财务状况，公司计划于 2023 年 9 月 7 日(周四)下午 14:00-16:30 参 加由 ...

Financial Performance - The company's operating revenue for Q1 2023 was CNY 199,595,462.29, representing an increase of 11.50% compared to the same period last year [3] - The net profit attributable to shareholders for Q1 2023 was CNY 9,795,174.23, reflecting a growth of 16.06% year-over-year [3] - Basic earnings per share for Q1 2023 were CNY 0.040, up by 14.29% from the previous year [3] - Total operating revenue for Q1 2023 reached ¥199,595,462.29, an increase of 11.0% compared to ¥179,002,475.46 in Q1 2022 [11] - Net profit for Q1 2023 was ¥9,080,552.75, representing a 24.0% increase from ¥7,320,355.27 in Q1 2022 [11] - Earnings per share for Q1 2023 were ¥0.040, compared to ¥0.035 in Q1 2022, marking a 14.3% increase [11] Cash Flow - The net cash flow from operating activities was negative at CNY -24,761,380.76, indicating a significant cash outflow [3] - Cash flow from operating activities showed a net outflow of ¥24,761,380.76 in Q1 2023, worsening from a net outflow of ¥17,377,534.45 in Q1 2022 [14] - Investment activities resulted in a net cash outflow of ¥50,014,416.03 in Q1 2023, compared to a smaller outflow of ¥512,015.94 in Q1 2022 [14] - Financing activities also showed a net cash outflow of ¥3,732,580.00 in Q1 2023, an improvement from an outflow of ¥7,164,163.19 in Q1 2022 [14] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,137,627,439.76, a decrease of 5.77% from the end of the previous year [3] - As of March 31, 2023, total assets amounted to ¥1,137,627,439.76, a decrease of approximately 5.77% from ¥1,207,255,505.50 on December 31, 2022 [8] - Current assets totaled ¥524,013,720.38, down 11.06% from ¥589,293,001.32 at the end of 2022 [8] - Total current liabilities were ¥358,026,106.61, a reduction of 17.73% from ¥435,213,299.44 [9] - The total liabilities amounted to ¥550,295,468.92, a decrease of 12.52% from ¥629,004,087.41 [9] Equity and Investments - The company's equity attributable to shareholders increased to ¥578,377,443.33, up from ¥568,582,269.10, reflecting a growth of 1.40% [9] - The company’s investment income increased by 129.23% compared to the previous year, attributed to gains from Shanghai Jing'an Pharmaceutical Co., Ltd. [5] - The company reported an increase in investment income to ¥1,358,685.13 in Q1 2023, up from ¥592,729.19 in Q1 2022 [11] Other Financial Metrics - The weighted average return on equity increased by 0.12 percentage points to 1.71% [3] - The company reported a significant increase in credit impairment losses by 425.94% due to a rise in bad debt provisions [5] - The company received government subsidies totaling CNY 5,547,800 during the reporting period, including CNY 3,847,900 on February 17, 2023 [7] - The company reported a decrease in inventory to ¥69,068,809.18, down 22.24% from ¥88,718,754.49 [8] - Cash and cash equivalents decreased to ¥222,422,833.06, a decline of 26.06% compared to ¥300,932,076.82 [8] - Accounts receivable stood at ¥150,113,420.39, down 9.23% from ¥165,407,141.33 [8] - Accounts payable decreased to ¥142,872,558.90, down 31.67% from ¥209,334,956.57 [9] - The non-current assets totaled ¥613,613,719.38, slightly down from ¥617,962,504.18, indicating a decrease of 0.56% [8]

| | | 上海开开实业股份有限公司 关于参加 2023 年上海辖区上市公司 年报集体业绩说明会的公告 ●会议召开地点：上证路演中心 （http://roadshow.sseinfo.com） ●会议召开方式：网络文字互动方式 ●投资者可在 2023 年 5 月 6 日 16:00 前 ， 通 过 公 司 邮 箱 dm@chinesekk.com提前留言提问。公司将在业绩说明会上对投资者普 遍关注的问题进行回答。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●会议召开时间：2023 年 5 月 10 日（星期三）下午 15:00-17:00 上海开开实业股份有限公司（以下简称"公司"）已于 2023 年 3 月 30 日在《上海证券报》《香港商报》及上海证券交易所网站 （www.sse.com.cn）披露了公司《2022 年年度报告及摘要》。并将于 2023 年 4 月 28 日在《上海证券报》《香港商报》及上海证券交易所 网站（www.sse.com.cn）披露公司《2023 年第一季度报告》。为进一 步 ...

Financial Performance - The company's operating revenue for Q1 2022 was CNY 179,002,475.46, representing a decrease of 6.53% compared to the same period last year[3]. - Net profit attributable to shareholders of the listed company reached CNY 8,440,101.50, a significant increase of 507.68% year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 2,941,866.39, down 35.83% compared to the previous year[3]. - The basic earnings per share for the period was CNY 0.035, reflecting an increase of 483.33% year-on-year[3]. - The company reported a net cash flow from operating activities of CNY -17,377,534.45, which is not applicable for comparison[3]. - Total operating revenue for Q1 2022 was ¥179,002,475.46, a decrease of 6.9% compared to ¥191,512,157.42 in Q1 2021[13]. - Net profit for Q1 2022 reached ¥7,320,355.27, compared to a net loss of ¥435,018.69 in Q1 2021, marking a significant turnaround[13]. - The profit attributable to shareholders of the parent company was ¥8,440,101.50 in Q1 2022, up from ¥1,388,901.35 in Q1 2021[13]. - Basic and diluted earnings per share for Q1 2022 were both ¥0.035, compared to ¥0.006 in Q1 2021[13]. - The company reported a total comprehensive income of ¥7,320,355.27 for Q1 2022, compared to ¥24,167.91 in Q1 2021[13]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,047,121,528.60, a decrease of 1.49% from the end of the previous year[3]. - Current assets decreased to CNY 407,472,925.84 from CNY 416,604,983.44, reflecting a decline of approximately 3.1%[10]. - Total liabilities decreased to CNY 499,818,566.71 from CNY 516,427,723.90, representing a reduction of about 3.2%[11]. - The company's cash and cash equivalents were CNY 148,449,189.59, down from CNY 173,503,223.58, indicating a decrease of approximately 14.5%[10]. - Total assets as of March 31, 2022, amounted to CNY 1,047,121,528.60, a decrease from CNY 1,062,971,330.52 as of December 31, 2021[10]. - Accounts receivable increased to CNY 127,396,628.75 from CNY 97,686,947.91, showing a growth of about 30.3%[10]. - Inventory decreased to CNY 85,518,764.76 from CNY 90,743,933.02, a decline of approximately 5.0%[10]. - The company reported a decrease in accounts payable from CNY 141,987,690.86 to CNY 131,208,713.29, a reduction of about 7.0%[11]. - Total equity increased slightly to CNY 547,302,961.89 from CNY 546,543,606.62, reflecting a marginal growth[11]. - The company’s retained earnings increased to CNY 222,233,819.90 from CNY 220,354,718.40, indicating a growth of approximately 0.8%[11]. Government Subsidies and Financial Activities - The company received government subsidies amounting to CNY 1,824,823.46, which are closely related to its normal business operations[4]. - The company incurred a financial expense of ¥1,442,664.33 in Q1 2022, compared to a financial income of ¥2,479,606.42 in Q1 2021[13]. - The company’s sales expenses decreased to ¥20,821,678.99 in Q1 2022 from ¥24,726,326.94 in Q1 2021, reflecting a cost control strategy[13]. Shareholder and Ownership Structure - The company has no significant related party transactions among the top shareholders, ensuring transparency in ownership structure[8]. - The weighted average return on equity was 1.59%, an increase of 1.32 percentage points compared to the end of the previous year[3]. - The equity attributable to shareholders of the listed company was CNY 537,310,591.98, an increase of 0.35% compared to the end of the previous year[3]. - The company experienced a 250.17% increase in notes receivable, indicating an increase in bank acceptance notes that were endorsed but not yet due at the end of the reporting period[6].